Page last updated: 2024-10-30

metformin and Ascites

metformin has been researched along with Ascites in 4 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Ascites: Accumulation or retention of free fluid within the peritoneal cavity.

Research Excerpts

ExcerptRelevanceReference
"In vivo, treatment of an ovarian cancer mouse model with metformin resulted in greater tumor weight reduction in normoglycemic vs."5.42Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer. ( Eckert, MA; Johnson, A; Lengyel, E; Litchfield, LM; Mills, KA; Mukherjee, A; Pan, S; Romero, IL; Shridhar, V, 2015)
"Ascites is associated with a high risk of death."1.72Incidence of, Risk Factors for, and Outcomes After Ascites in a Population-Based Cohort of Older Americans. ( Mazumder, N; Parikh, ND; Tapper, EB; Zhao, Z, 2022)
"Ovarian cancer is the most lethal gynecological malignancy in women."1.62Metformin Affects the Transcriptomic Profile of Chicken Ovarian Cancer Cells. ( Albert, I; Gopalan, L; Praul, CA; Ramachandran, R; Sebastian, A, 2021)
"In vivo, treatment of an ovarian cancer mouse model with metformin resulted in greater tumor weight reduction in normoglycemic vs."1.42Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer. ( Eckert, MA; Johnson, A; Lengyel, E; Litchfield, LM; Mills, KA; Mukherjee, A; Pan, S; Romero, IL; Shridhar, V, 2015)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Gopalan, L1
Sebastian, A1
Praul, CA1
Albert, I1
Ramachandran, R1
Tapper, EB1
Zhao, Z1
Mazumder, N1
Parikh, ND1
Saffo, S1
Kaplan, DE1
Mahmud, N1
Serper, M1
John, BV1
Ross, JS1
Taddei, T1
Litchfield, LM1
Mukherjee, A1
Eckert, MA1
Johnson, A1
Mills, KA1
Pan, S1
Shridhar, V1
Lengyel, E1
Romero, IL1

Other Studies

4 other studies available for metformin and Ascites

ArticleYear
Metformin Affects the Transcriptomic Profile of Chicken Ovarian Cancer Cells.
    Genes, 2021, 12-23, Volume: 13, Issue:1

    Topics: Animals; Ascites; Cell Line, Tumor; Cell Proliferation; Chickens; Down-Regulation; Epithelial-Mesenc

2021
Incidence of, Risk Factors for, and Outcomes After Ascites in a Population-Based Cohort of Older Americans.
    Digestive diseases and sciences, 2022, Volume: 67, Issue:11

    Topics: Aged; Anticoagulants; Antiviral Agents; Ascites; Atorvastatin; Carvedilol; Diuretics; Fibrosis; Huma

2022
Impact of SGLT2 inhibitors in comparison with DPP4 inhibitors on ascites and death in veterans with cirrhosis on metformin.
    Diabetes, obesity & metabolism, 2021, Volume: 23, Issue:10

    Topics: Ascites; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Huma

2021
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer.
    Oncotarget, 2015, Sep-15, Volume: 6, Issue:27

    Topics: Animals; Antineoplastic Agents; Ascites; Cell Line, Tumor; Cell Survival; Female; Gene Expression Re

2015